Free Trial

First Trust Advisors LP Sells 28,639 Shares of Centene Co. (NYSE:CNC)

Centene logo with Medical background

First Trust Advisors LP lowered its stake in shares of Centene Co. (NYSE:CNC - Free Report) by 4.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 576,600 shares of the company's stock after selling 28,639 shares during the period. First Trust Advisors LP owned 0.11% of Centene worth $34,930,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in CNC. Capital Advisors Ltd. LLC lifted its holdings in Centene by 75.3% during the 4th quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company's stock worth $25,000 after purchasing an additional 177 shares in the last quarter. Hurley Capital LLC bought a new stake in shares of Centene during the fourth quarter valued at about $26,000. Rialto Wealth Management LLC purchased a new stake in shares of Centene in the fourth quarter worth about $30,000. OFI Invest Asset Management purchased a new position in Centene during the fourth quarter valued at approximately $33,000. Finally, SRS Capital Advisors Inc. increased its holdings in Centene by 73.4% during the 4th quarter. SRS Capital Advisors Inc. now owns 631 shares of the company's stock worth $38,000 after acquiring an additional 267 shares during the period. 93.63% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

CNC has been the subject of several analyst reports. Wells Fargo & Company cut their price target on shares of Centene from $76.00 to $72.00 and set an "overweight" rating for the company in a report on Friday, February 14th. Robert W. Baird dropped their price objective on Centene from $71.00 to $69.00 and set a "neutral" rating for the company in a research note on Tuesday, April 15th. Argus lowered Centene from a "buy" rating to a "hold" rating in a research note on Thursday, February 6th. Guggenheim began coverage on Centene in a research report on Wednesday, April 9th. They set a "neutral" rating for the company. Finally, StockNews.com upgraded shares of Centene from a "buy" rating to a "strong-buy" rating in a research report on Friday, April 11th. Seven research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $80.69.

Get Our Latest Report on CNC

Centene Stock Down 1.1 %

Shares of NYSE:CNC opened at $61.46 on Friday. Centene Co. has a 12-month low of $55.03 and a 12-month high of $80.59. The company has a current ratio of 1.11, a quick ratio of 1.10 and a debt-to-equity ratio of 0.70. The stock's 50-day moving average price is $60.06 and its 200-day moving average price is $61.06. The stock has a market capitalization of $30.49 billion, a P/E ratio of 9.85, a price-to-earnings-growth ratio of 0.80 and a beta of 0.53.

Centene (NYSE:CNC - Get Free Report) last announced its quarterly earnings results on Tuesday, February 4th. The company reported $0.80 EPS for the quarter, topping analysts' consensus estimates of $0.49 by $0.31. The business had revenue of $40.81 billion for the quarter, compared to analysts' expectations of $38.78 billion. Centene had a return on equity of 13.85% and a net margin of 2.03%. The business's quarterly revenue was up 3.4% on a year-over-year basis. During the same period in the previous year, the firm earned $0.45 EPS. On average, equities analysts anticipate that Centene Co. will post 6.86 earnings per share for the current year.

Centene Profile

(Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.

Further Reading

Institutional Ownership by Quarter for Centene (NYSE:CNC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Centene Right Now?

Before you consider Centene, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.

While Centene currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Make Your Money Work Harder: The Power of Dividend Investing
7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines